Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression
Daoyan Wei, Liang Wang, Yi Liu, Margarete Hafley, Lin Tan, Philip L. Lorenzi, Peiying Yang, Xiangsheng Zuo, Robert S. Bresalier
Topics & Concepts
Calcitriol receptorGemcitabineCancer researchPancreatic cancerMedicineVitamin D and neurologyMUC1ParicalcitolInternal medicinePharmacologyEndocrinologyCancerCalciumSecondary hyperparathyroidismParathyroid hormoneGlycosylation and Glycoproteins ResearchVitamin D Research StudiesCancer, Hypoxia, and Metabolism